Development of Physiologically Based Pharmacokinetic Model for Pregabalin to Predict the Pharmacokinetics in Pediatric Patients with Renal Impairment and Adjust Dosage Regimens-Reference-Cited by-同舟云学术

Development of Physiologically Based Pharmacokinetic Model for Pregabalin to Predict the Pharmacokinetics in Pediatric Patients with Renal Impairment and Adjust Dosage Regimens

Published:2022-02 Issue:2 Volume:111 Page:542-551
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Ke Chengjie,You Xiang,Lin Cuihong,Chen Jiarui,Guo Guimu,Wu Wanhong,Ye Lingling,Huang Pinfang

Funder

Department of Education, Fujian Province

Fujian Medical University

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference48 articles.

1. Pregabalin monotherapy in patients with partial-onset seizures: a historical-controlled trial;French;Neurology,2014

2. Pregabalin long-term treatment and assessment of discontinuation in patients with generalized anxiety disorder;Kasper;Int J Neuropsychopharmacol,2014

3. Efficacy and safety of pregabalin in patients with fibromyalgia and comorbid depression taking concurrent antidepressant medication: a randomized, placebo-controlled study;Arnold;J Rheumatol,2015

4. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial;Dworkin;Neurology,2003

5. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial;Richter;J Pain,2005

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic kidney disease and physiologically based pharmacokinetic modeling: a critical review of existing models;Expert Opinion on Drug Metabolism & Toxicology;2024-01-31

2. Regulatory Requirements and Applications of Physiologically Based Pharmacokinetic Models;ADME Processes in Pharmaceutical Sciences;2024

3. Prediction of pharmacokinetics of an anaplastic lymphoma kinase inhibitor in rat and monkey: application of physiologically based pharmacokinetic model as an alternative tool to minimise animal studies;Xenobiotica;2023-12-02

4. Lamivudine and Emtricitabine Dosing Proposal for Children with HIV and Chronic Kidney Disease, Supported by Physiologically Based Pharmacokinetic Modelling;Pharmaceutics;2023-05-06

5. Pan-Genomics of Escherichia albertii for Antibiotic Resistance Profiling in Different Genome Fractions and Natural Product Mediated Intervention: In Silico Approach;Life;2023-02-15